roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we … estimate models of price responses to generic entry in the market for brand-name and generic drugs. We study a sample of 32 … drugs that lost patent protection during the early to mid-1980s. Our results provide strong evidence that brand-name prices …

Efforts to strengthen the global patent system for pharmaceuticals continue to be controversial, and what will likely …

We examine the role of network effects in the demand for pharmaceuticals at both the brand level and for a therapeutic … hedonic price procedures to estimate how the aggregate usage of a drug affects brand valuation. Second, we estimate discrete …-time diffusion models at both the industry and brand levels to measure the impact on rates of diffusion and market saturation …

branded pharmaceuticals. We then present a theoretical framework for the pricing of branded pharmaceuticals, without and then …

affects prices to retail pharmacies, plausibly because uncertain quality leads to competition on brand rather than price …

competition after entry. However, less attention has been paid to pricing behavior in anticipation of brand-to-brand competition …

We examine the role of consumption externalities in the demand for pharmaceuticals at both the brand level and over a … brand valuation; equations relating equilibrium market shares to quality-adjusted prices and marketing levels; and diffusion … of diffusion, but that they operate at the brand and not the therapeutic class level …

Prescription pharmaceuticals are frequently used consumer products, whose manufacturing location is commonly held as a … and trends in the manufacturing locations of the most commonly used prescription pharmaceuticals, off-patent generic drugs …